
If you’ve been following discussions about the Medicare GLP-1 Bridge program, you’ve probably noticed a pattern: a large number of people are reporting denials, especially those who have sleep apnea.
This is not a coincidence. It is the result of a clear rule set by the Centers for Medicare & Medicaid Services (CMS).
The Official Rule
According to CMS, people who have a diagnosis of moderate-to-severe obstructive sleep apnea (OSA) are not eligible for the Medicare GLP-1 Bridge program.
Here’s why:
- The Bridge program is only for people seeking GLP-1 medications (such as Zepbound KwikPen, Wegovy, or Foundayo) purely for weight management.
- Moderate-to-severe sleep apnea is already considered a covered indication under regular Medicare Part D.
- Zepbound has an FDA-approved indication specifically for moderate-to-severe obstructive sleep apnea in adults with obesity.
- Because of this, CMS requires that anyone with this diagnosis go through their regular Part D plan instead of the Bridge program.
If a doctor submits a prior authorization to the Bridge program and the patient has an OSA diagnosis on record, the request will be denied.
Other Common Reasons for Denial
While sleep apnea is one of the biggest triggers, it is not the only reason people are being turned down. Other frequent denial reasons include:
- Having Type 2 diabetes
- Having noncirrhotic MASH (a form of fatty liver disease)
- Already receiving a GLP-1 medication through a Part D plan
- Not meeting the BMI requirements at the time GLP-1 therapy was started
- Being prescribed a form of Zepbound that is not covered (only the KwikPen is allowed under the Bridge)
- Incomplete prior authorization paperwork
What to Do If You Are Denied (Appeal Process)
This is an important point that many people do not realize:
The Medicare GLP-1 Bridge program currently does not have a formal appeals process.
Unlike regular Medicare Part D denials (which have multiple levels of appeal), CMS has stated that there is no standard appeal pathway for Bridge program denials at this time.
What you can do:
- Resubmit the prior authorization
If the denial was caused by missing or incorrect information, your doctor can correct the paperwork and resubmit it. - Review the exact denial reason
Both you and your doctor should receive a denial letter. Read it carefully. Many denials happen because the wrong pathway was used (for example, submitting to the Bridge when the patient has sleep apnea). - Switch pathways if needed
- If you have moderate-to-severe sleep apnea → Try submitting through your regular Part D plan using the sleep apnea indication.
- If you do not have a Part D-covered diagnosis → Work with your doctor to fix any documentation problems and resubmit to the Bridge.
- Contact the Bridge Call Center
Prescribers can call the Medicare GLP-1 Bridge Call Center at 855-273-0102 (Monday–Friday, 8 a.m. – 7 p.m. ET) for questions about a specific prior authorization.
Can New Information Help After a Past Sleep Apnea Diagnosis?
Some people were diagnosed with obstructive sleep apnea (OSA) years ago but believe their condition has improved. In these cases, a few readers have asked whether updated information — such as overnight oxygen saturation (SpO2) readings from a fitness tracker — can make a difference.
While consumer devices like Garmin watches can track SpO2 trends during sleep and may show consistently normal oxygen levels, they are not considered a formal medical diagnosis. Medicare and the Bridge program generally require official clinical documentation, such as a recent sleep study or an updated evaluation from your doctor.
If you previously had an OSA diagnosis but believe it is no longer accurate, the most useful step is to:
- Discuss your current symptoms (or lack of symptoms) with your doctor
- Share any overnight SpO2 data you have collected
- Ask whether a new sleep study or updated clinical note is appropriate
Your doctor can then decide whether the older OSA diagnosis should still be listed on a Bridge program application or whether the case should instead be submitted through regular Part D using a different indication.
Final Thoughts:
The Medicare GLP-1 Bridge program has helped many seniors gain access to these medications at a lower cost. However, it was never designed for everyone. CMS intentionally excluded people with certain diagnoses, including moderate-to-severe sleep apnea, so those cases would stay under the normal Part D system.
If you were denied, the first and most important step is to understand the exact reason. In many cases, the solution is not an “appeal” but using the correct coverage pathway or correcting the original submission.